Jin-ah Sim

Dr. Jin-ah Sim


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2022 in Children
Verified
Journal Article
Open access
PDF file
MHMadeline Horan
Madeline Horan
JSJin-ah Sim
Jin-ah Sim
Kevin KrullKevin Krull
Kevin Krull
JBJustin N. Baker
Justin N. Baker
IHI-Chan Huang
I-Chan Huang
Patient-reported outcomes (PROs) are used in clinical work and research to capture the subjective experiences of childhood cancer patients and survivors. PROs encompass content domains relevant and important to this population, including health-related quality-of-life (HRQOL), symptoms, and functional status. To inform future efforts in the application of PRO measures, this review describes the existing generic and cancer-specific PRO measures for pediatric cancer populations and summarizes their characteristics, available language translations, content coverage, and measurement properties into tables for clinicians and researchers to reference before choosing a PRO measure that suits their purpose. We have identified often unreported measurement properties that could provide evidence about the clinical utility of the PRO measures. Routine PRO assessment in pediatric cancer care offers opportunities to facilitate clinical decision-making and improve quality of care for these patients. However, we suggest that before implementing PRO measures into research or clinical care, the psychometric properties and content coverage of the PRO measures must be considered to ensure that PRO measures are appropriately assessing the intended construct in childhood cancer patients.

YYYoung Ho Yun
Young Ho Yun
JSJin-ah Sim
Jin-ah Sim
YCYeani Choi
Yeani Choi
HYHyejeong Yoon
Hyejeong Yoon
This study aimed to investigate the general South Korean public attitudes toward the legalization of euthanasia or physician-assisted suicide (EAS) and examine the reasons underpinning these attitudes. From March–April 2021, we conducted a cross-sectional survey of a representative national sample of 1000 South Koreans aged 19 years or older. Three in four participants (76.4%) expressed positive attitudes toward the legalization of EAS. Participants who agreed with this legalization reported “meaninglessness of the rest of life” and “right to a good death” as their main reasons. Participants who disagreed with the legalization of EAS reported “respect for life”, “violation of the right to self-determination”, “risk of abuse or overuse”, and “violation of human rights” as theirs. In the multivariate logistic regression analyses, participants with poor physical status (adjusted odds ratio [aOR]: 1.41, 95%; confidence interval [CI]: 1.02–1.93) or comorbidity (aOR: 1.84, 95%; CI: 1.19–2.83) showed positive attitudes toward the legalization of EAS. In summary, most of the general South Korean population regards the legalization of EAS positively, especially participants with poor physical status or comorbidity.

6 February 2023 in Cancers
Verified
Journal Article
Open access
PDF file
MHMadeline Horan
Madeline Horan
JSJin-ah Sim
Jin-ah Sim
Kevin KrullKevin Krull
Kevin Krull
KNKirsten Ness
Kirsten Ness
YYYutaka Yasui
Yutaka Yasui
IHI-Chan Huang
I-Chan Huang
Patient-reported outcome measures (PROMs) are subjective assessments of health status or health-related quality of life. In childhood cancer survivors, PROMs can be used to evaluate the adverse effects of cancer treatment and guide cancer survivorship care. However, there are barriers to integrating PROMs into clinical practice, such as constraints in clinical validity, meaningful interpretation, and technology-enabled administration of the measures. This article discusses these barriers and proposes 10 important considerations for appropriate PROM integration into clinical care for choosing the right measure (considering the purpose of using a PROM, health profile vs. health preference approaches, measurement properties), ensuring survivors complete the PROMs (data collection method, data collection frequency, survivor capacity, self- vs. proxy reports), interpreting the results (scoring methods, clinical meaning and interpretability), and selecting a strategy for clinical response (integration into the clinical workflow). An example framework for integrating novel patient-reported outcome (PRO) data collection into the clinical workflow for childhood cancer survivorship care is also discussed. As we continuously improve the clinical validity of PROMs and address implementation barriers, routine PRO assessment and monitoring in pediatric cancer survivorship offer opportunities to facilitate clinical decision making and improve the quality of survivorship care.

2 September 2025 in JAMA Network Open
Verified
Journal Article
Open access
JKJeong-Han Kim
Jeong-Han Kim
JYJiwon Yu
Jiwon Yu
SYShin Hye Yoo
Shin Hye Yoo
JSJin-ah Sim
Jin-ah Sim
BKBhumsuk Keam
Bhumsuk Keam
DHDae Seog Heo
Dae Seog Heo
Importance: Patients with advanced cancer frequently receive broad-spectrum antibiotics, but changing use patterns across the end-of-life trajectory remain poorly understood.Objective: To describe the patterns of broad-spectrum antibiotic use across defined end-of-life intervals in patients with advanced cancer.Design, Setting, and Participants: This nationwide, population-based, retrospective cohort study used data from the South Korean National Health Insurance Service database to examine broad-spectrum antibiotic use among patients with advanced cancer who died between July 1, 2002, and December 31, 2021. Data extraction and analysis were conducted between September 2023 and August 2024.Exposure: A diagnosis of lung cancer, liver cancer, stomach cancer, colorectal cancer, pancreatic cancer, prostate cancer, gallbladder and biliary tract cancer, breast cancer, non-Hodgkin lymphoma, leukemia, or multiple myeloma.Main Outcomes and Measures: The use of broad-spectrum antibiotics (ie, antipseudomonal β-lactams, carbapenems, or glycopeptides) was evaluated using 2 metrics according to end-of-life trajectory: (1) prescription proportion (percentage of patients receiving antibiotics) and (2) consumption amount (days of therapy per 1000 patient-days). The end-of-life trajectory was divided into 5 intervals: T1 (6 months to 3 months before death), T2 (3 months to 1 month before death), T3 (1 month to 2 weeks before death), T4 (2 weeks to 1 week before death), and T5 (final week before death). Logistic regression was performed to calculate odds ratios and 95% CIs for antibiotic prescription proportion without adjustment for multiple comparisons, and Poisson regression was used to calculate adjusted relative risks.Results: Among the 515 366 decedents included, the mean (SD) age was 68.8 (11.7) years, and 347 327 (67.4%) were male. A total of 483 405 patients (93.8%) had solid tumors, with lung cancer (122 142 patients [23.7%]) being the most common type. Overall, 288 151 patients (55.9%) received broad-spectrum antibiotics during the last 6 months of life. The proportion of patients receiving broad-spectrum antibiotics peaked during T2, with 144 920 (28.1%) receiving at least 1 dose, and declined to 68 564 (13.3%) during T5. In contrast, total consumption peaked during T3, reaching 190.0 days of therapy per 1000 patient-days. These patterns were consistent across antibiotic classes and cancer types. During the last week of life, patients with leukemia had the highest exposure to broad-spectrum antibiotics compared with those with lung cancer, both for prescription proportions (crude odds ratio, 1.50; 95% CI, 1.43-1.58) and total consumption (adjusted relative risk, 1.21; 95% CI, 1.19-1.23).Conclusions and Relevance: In this cohort study of patients with advanced cancer, broad-spectrum antibiotic use increased from 3 months to 2 weeks before death, suggesting that this may be a key period for optimizing use and aligning care with patient goals.

12 October 2021 in Frontiers in Public Health
Verified
Journal Article
Open access
SPSoowon Park
Soowon Park
YKYaeji Kim-Knauss
Yaeji Kim-Knauss
JSJin-ah Sim
Jin-ah Sim
Online inquiry platforms, which is where a person can anonymously ask questions, have become an important information source for those who are concerned about social stigma and discrimination that follow mental disorders. Therefore, examining what people inquire about regarding mental disorders would be useful when designing educational programs for communities. The present study aimed to examine the contents of the queries regarding mental disorders that were posted on online inquiry platforms. A total of 4,714 relevant queries from the two major online inquiry platforms were collected. We computed word frequencies, centralities, and latent Dirichlet allocation (LDA) topic modeling. The words like symptom, hospital and treatment ranked as the most frequently used words, and the word my appeared to have the highest centrality. LDA identified four latent topics: (1) the understanding of general symptoms, (2) a disability grading system and welfare entitlement, (3) stressful life events, and (4) social adaptation with mental disorders. People are interested in practical information concerning mental disorders, such as social benefits, social adaptation, more general information about the symptoms and the treatments. Our findings suggest that instructions encompassing different scopes of information are needed when developing educational programs.

25 April 2024 in Cancers
Verified
Journal Article
Open access
PDF file
JSJin-ah Sim
Jin-ah Sim
MHMadeline Horan
Madeline Horan
JCJaesung Choi
Jaesung Choi
DSDeokumar Srivastava
Deokumar Srivastava
GAGregory T. Armstrong
Gregory T. Armstrong
IHI-Chan Huang
I-Chan Huang
In this study, the social determinants of patient-reported outcomes (PROs) in young survivors of childhood cancer aged <18 years are researched. This cross-sectional study investigated social determinants associated with poor PROs among young childhood cancer survivors. We included 293 dyads of survivors receiving treatment at St. Jude Children’s Research Hospital who were <18 years of age during follow-up from 2017 to 2018 and their primary caregivers. Social determinants included family factors (caregiver-reported PROs, family dynamics) and county-level deprivation (socioeconomic status, physical environment via the County Health Rankings & Roadmaps). PROMIS measures assessed survivors’ and caregivers’ PROs. General linear regression tested associations of social determinants with survivors’ PROs. We found that caregivers’ higher anxiety was significantly associated with survivors’ poorer depression, stress, fatigue, sleep issues, and reduced positive affect (p < 0.05); caregivers’ sleep disturbances were significantly associated with lower mobility in survivors (p < 0.05). Family conflicts were associated with survivors’ sleep problems (p < 0.05). Residing in socioeconomically deprived areas was significantly associated with survivors’ poorer sleep quality (p < 0.05), while higher physical environment deprivation was associated with survivors’ higher psychological stress and fatigue and lower positive affect and mobility (p < 0.05). Parental, family, and neighborhood factors are critical influences on young survivors’ quality of life and well-being and represent new intervention targets.